Similar articles for PMID: 32620617

Year	Number of Results
2005	1
2008	1
2010	1
2011	1
2012	1
2013	1
2014	5
2015	13
2016	18
2017	10
2018	21
2019	15
2020	8
2021	9
2022	2
2024	0

1

Pan- and Isoform-specific Inhibition of the Bromodomain and Extra-terminal Proteins and Evaluation of Synergistic Potential With Entospletinib in Canine Lymphoma.

Kong W, Sender S, Perez SV, Sekora A, Ruetgen B, Junghanss C, Nolte I, Murua Escobar H. Kong W, et al. Anticancer Res. 2020 Jul;40(7):3781-3792. doi: 10.21873/anticanres.14367. Anticancer Res. 2020. PMID: 32620617

2

Evaluation of the Synergistic Potential of Simultaneous Pan- or Isoform-Specific BET and SYK Inhibition in B-Cell Lymphoma: An In Vitro Approach.

Sender S, Sultan AW, Palmer D, Koczan D, Sekora A, Beck J, Schuetz E, Taher L, Brenig B, Fuellen G, Junghanss C, Murua Escobar H. Sender S, et al. Cancers (Basel). 2022 Sep 27;14(19):4691. doi: 10.3390/cancers14194691. Cancers (Basel). 2022. PMID: 36230614 Free PMC article.

3

Precursor B-ALL Cell Lines Differentially Respond to SYK Inhibition by Entospletinib.

Sender S, Sekora A, Villa Perez S, Chabanovska O, Becker A, Ngezahayo A, Junghanss C, Murua Escobar H. Sender S, et al. Int J Mol Sci. 2021 Jan 8;22(2):592. doi: 10.3390/ijms22020592. Int J Mol Sci. 2021. PMID: 33435587 Free PMC article.

4

An Open-label, Phase II Trial of Entospletinib (GS-9973), a Selective Spleen Tyrosine Kinase Inhibitor, in Diffuse Large B-cell Lymphoma.

Burke JM, Shustov A, Essell J, Patel-Donnelly D, Yang J, Chen R, Ye W, Shi W, Assouline S, Sharman J. Burke JM, et al. Clin Lymphoma Myeloma Leuk. 2018 Aug;18(8):e327-e331. doi: 10.1016/j.clml.2018.05.022. Epub 2018 Jun 6. Clin Lymphoma Myeloma Leuk. 2018. PMID: 29934062 Free PMC article. Clinical Trial.

5

NF-κB signaling activation via increases in BRD2 and BRD4 confers resistance to the bromodomain inhibitor I-BET151 in U937 cells.

Hishiki K, Akiyama M, Kanegae Y, Ozaki K, Ohta M, Tsuchitani E, Kaito K, Yamada H. Hishiki K, et al. Leuk Res. 2018 Nov;74:57-63. doi: 10.1016/j.leukres.2018.09.016. Epub 2018 Oct 2. Leuk Res. 2018. PMID: 30300821

6

Dual targeting of bromodomain-containing 4 by AZD5153 and BCL2 by AZD4320 against B-cell lymphomas concomitantly overexpressing c-MYC and BCL2.

Takimoto-Shimomura T, Tsukamoto T, Maegawa S, Fujibayashi Y, Matsumura-Kimoto Y, Mizuno Y, Chinen Y, Shimura Y, Mizutani S, Horiike S, Taniwaki M, Kobayashi T, Kuroda J. Takimoto-Shimomura T, et al. Invest New Drugs. 2019 Apr;37(2):210-222. doi: 10.1007/s10637-018-0623-8. Epub 2018 Jun 21. Invest New Drugs. 2019. PMID: 29931583

7

Scaffold hopping of the SYK inhibitor entospletinib leads to broader targeting of the BCR signalosome.

Jorda R, Krajčovičová S, Králová P, Soural M, Kryštof V. Jorda R, et al. Eur J Med Chem. 2020 Oct 15;204:112636. doi: 10.1016/j.ejmech.2020.112636. Epub 2020 Jul 19. Eur J Med Chem. 2020. PMID: 32731189

8

The bromodomain protein inhibitor I-BET151 suppresses expression of inflammatory genes and matrix degrading enzymes in rheumatoid arthritis synovial fibroblasts.

Klein K, Kabala PA, Grabiec AM, Gay RE, Kolling C, Lin LL, Gay S, Tak PP, Prinjha RK, Ospelt C, Reedquist KA. Klein K, et al. Ann Rheum Dis. 2016 Feb;75(2):422-9. doi: 10.1136/annrheumdis-2014-205809. Epub 2014 Dec 2. Ann Rheum Dis. 2016. PMID: 25467295

9

AZD5153: A Novel Bivalent BET Bromodomain Inhibitor Highly Active against Hematologic Malignancies.

Rhyasen GW, Hattersley MM, Yao Y, Dulak A, Wang W, Petteruti P, Dale IL, Boiko S, Cheung T, Zhang J, Wen S, Castriotta L, Lawson D, Collins M, Bao L, Ahdesmaki MJ, Walker G, O'Connor G, Yeh TC, Rabow AA, Dry JR, Reimer C, Lyne P, Mills GB, Fawell SE, Waring MJ, Zinda M, Clark E, Chen H. Rhyasen GW, et al. Mol Cancer Ther. 2016 Nov;15(11):2563-2574. doi: 10.1158/1535-7163.MCT-16-0141. Epub 2016 Aug 29. Mol Cancer Ther. 2016. PMID: 27573426

10

BTK and PI3K Inhibitors Reveal Synergistic Inhibitory Anti-Tumoral Effects in Canine Diffuse Large B-Cell Lymphoma Cells.

Kong W, Sender S, Taher L, Villa-Perez S, Ma Y, Sekora A, Ruetgen BC, Brenig B, Beck J, Schuetz E, Junghanss C, Nolte I, Murua Escobar H. Kong W, et al. Int J Mol Sci. 2021 Nov 24;22(23):12673. doi: 10.3390/ijms222312673. Int J Mol Sci. 2021. PMID: 34884478 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

89 results

Results by year